82 related articles for article (PubMed ID: 38664758)
21. Characteristics, management and outcome of primary hyperparathyroidism in South Africa: a single-centre experience.
Paruk IM; Esterhuizen TM; Maharaj S; Pirie FJ; Motala AA
Postgrad Med J; 2013 Nov; 89(1057):626-31. PubMed ID: 23824345
[TBL] [Abstract][Full Text] [Related]
22. Two cases of spontaneous remission of primary hyperparathyroidism due to auto-infarction: different management and their outcomes.
Novodvorsky P; Hussein Z; Arshad MF; Iqbal A; Fernando M; Munir A; Balasubramanian SP
Endocrinol Diabetes Metab Case Rep; 2019 May; 2019():. PubMed ID: 31063971
[TBL] [Abstract][Full Text] [Related]
23. Influence of age and gender on presentation of symptomatic primary hyperparathyroidism.
Shah VN; Bhadada SK; Bhansali A; Behera A; Mittal BR; Bhavin V
J Postgrad Med; 2012; 58(2):107-11. PubMed ID: 22718053
[TBL] [Abstract][Full Text] [Related]
24. Primary hyperparathyroidism: findings from the retrospective evaluation of cases over a 6-year period from a regional UK centre.
Pappachan JM; Elnaggar MN; Sodi R; Jbeili K; Smith PR; Lahart IM
Endocrine; 2018 Oct; 62(1):174-181. PubMed ID: 30019307
[TBL] [Abstract][Full Text] [Related]
25. Forestalling Hungry Bone Syndrome after Parathyroidectomy in Patients with Primary and Renal Hyperparathyroidism.
Carsote M; Nistor C
Diagnostics (Basel); 2023 Jun; 13(11):. PubMed ID: 37296804
[TBL] [Abstract][Full Text] [Related]
26. The impact of vitamin D deficiency on clinical, biochemical and metabolic parameters in primary hyperparathyroidism.
Şengül Ayçiçek G; Aydoğan Bİ; Şahin M; Emral R; Erdoğan MF; Güllü S; Başkal N; Çorapçıoğlu D
Endocrinol Diabetes Nutr (Engl Ed); 2023 Jan; 70(1):56-62. PubMed ID: 36764749
[TBL] [Abstract][Full Text] [Related]
27. The value of intraoperative parathyroid hormone monitoring in patients with primary hyperparathyroidism and varying baseline parathyroid hormone levels.
Hargitai L; Bereuter CM; Dunkler D; Geroldinger A; Scheuba C; Niederle B; Riss P
BJS Open; 2022 Nov; 6(6):. PubMed ID: 36515670
[TBL] [Abstract][Full Text] [Related]
28. Evaluation and Management of Primary Hyperparathyroidism: Summary Statement and Guidelines from the Fifth International Workshop.
Bilezikian JP; Khan AA; Silverberg SJ; Fuleihan GE; Marcocci C; Minisola S; Perrier N; Sitges-Serra A; Thakker RV; Guyatt G; Mannstadt M; Potts JT; Clarke BL; Brandi ML;
J Bone Miner Res; 2022 Nov; 37(11):2293-2314. PubMed ID: 36245251
[TBL] [Abstract][Full Text] [Related]
29. Primary hyperparathyroidism in Saudi Arabia revisited: a multi-centre observational study.
Al-Saleh Y; AlSohaim A; AlAmoudi R; AlQarni A; Alenezi R; Mahdi L; Alzanbaqi H; Nawar SM; AlHarbi H; ALMulla A; Al Qahtani M; Salih SB; Al Anazi F; Saleh N; Saleh S; AlAklabi A; Sabico S; Al-Daghri NM
BMC Endocr Disord; 2022 Jun; 22(1):155. PubMed ID: 35676656
[TBL] [Abstract][Full Text] [Related]
30. Hungry bone syndrome following parathyroidectomy for primary hyperparathyroidism in a developed country in the Asia Pacific. A cohort study.
Chandran M; Bilezikian JP; Salleh NM; Ying H; Lau J; Lee J; deJong MC; Chan Maung A; Parameswaran R
Osteoporos Sarcopenia; 2022 Mar; 8(1):11-16. PubMed ID: 35415277
[TBL] [Abstract][Full Text] [Related]
31. Interpretation of intraoperative parathyroid hormone monitoring according to the Rome criterion in primary hyperparathyroidism.
Graceffa G; Cipolla C; Calagna S; Contino S; Melfa G; Orlando G; Antonini R; Corigliano A; Proclamà MP; Mazzola S; Cocorullo G; Scerrino G
Sci Rep; 2022 Feb; 12(1):3333. PubMed ID: 35228624
[TBL] [Abstract][Full Text] [Related]
32. Preoperative Localization for Primary Hyperparathyroidism: A Clinical Review.
Tay D; Das JP; Yeh R
Biomedicines; 2021 Apr; 9(4):. PubMed ID: 33917470
[TBL] [Abstract][Full Text] [Related]
33. Monocentric experience of primary hyperparathyroidism surgery in Algeria.
Nouikes Zitouni S
Surg Open Sci; 2021 Apr; 4():32-36. PubMed ID: 33748732
[TBL] [Abstract][Full Text] [Related]
34. Clinical Characteristics of Primary Hyperparathyroidism: 15-Year Experience of 457 Patients in a Single Center in China.
Lin X; Fan Y; Zhang Z; Yue H
Front Endocrinol (Lausanne); 2021; 12():602221. PubMed ID: 33716964
[TBL] [Abstract][Full Text] [Related]
35. Role of Bisphosphonates in The Prevention of Postoperative Hungry Bone Syndrome in Primary Hyperparathyroidism: A Meta-Analysis and Need for Randomized Controlled Trials.
Pal R; Gautam A; Bhadada SK
Drug Res (Stuttg); 2021 Feb; 71(2):108-109. PubMed ID: 33296924
[TBL] [Abstract][Full Text] [Related]
36. Changes in bone mineral density after parathyroidectomy in patients with moderate to severe primary hyperparathyroidism.
Lu S; Gong M; Zha Y; Cui A; Chen C; Yang H; Sun W; Hua K; Tian W; Jiang X
J Int Med Res; 2020 Oct; 48(10):300060520964698. PubMed ID: 33135515
[TBL] [Abstract][Full Text] [Related]
37. Identification of independent factors affecting bone mineral density after successful parathyroidectomy for symptomatic hyperparathyroidism.
Lu S; Gong M; Zha Y; Cui A; Chen C; Sun W; Hua K; Tian W; Jiang X
BMC Endocr Disord; 2020 Sep; 20(1):141. PubMed ID: 32928178
[TBL] [Abstract][Full Text] [Related]
38. Primary hyperparathyroidism in developing world: a systematic review on the changing clinical profile of the disease.
Yadav SK; Johri G; Bichoo RA; Jha CK; Kintu-Luwaga R; Mishra SK
Arch Endocrinol Metab; 2020 Apr; 64(2):105-110. PubMed ID: 32236309
[TBL] [Abstract][Full Text] [Related]
39. Normocalcemic Hyperparathyroidism: Study of its Prevalence and Natural History.
Schini M; Jacques RM; Oakes E; Peel NFA; Walsh JS; Eastell R
J Clin Endocrinol Metab; 2020 Apr; 105(4):e1171-86. PubMed ID: 32072184
[TBL] [Abstract][Full Text] [Related]
40. Resolution of hypercalcemia in primary hyperparathyroidism with vitamin D replacement.
Rojas AP; Fain K; Peiris AN
Proc (Bayl Univ Med Cent); 2020 Jan; 33(1):40-41. PubMed ID: 32063763
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
